Vimarsana
Biggest News Aggregation in the World

Page 21 - High Throughput Screening News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from High Throughput Screening. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In High Throughput Screening Today - Breaking & Trending Today

Penn researchers discover drug that blocks multiple SARS-CoV-2 variants in mice - Vimarsana News

Penn researchers discover drug that blocks multiple SARS-CoV-2 variants in mice

 E-Mail The drug diABZI -- which activates the body's innate immune response -- was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Science Immunology, suggest that diABZI could also treat other respiratory coronaviruses. "Few drugs have been identified as game-changers in blocking SARS-CoV-2 infection. This paper is the first to show that activating an early immune response therapeutically with a single dose is a pr...

The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company's Personalized Medicine Drug Discovery Technology - Vimarsana News

The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company's Personalized Medicine Drug Discovery Technology

The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company's Personalized Medicine Drug Discovery Technology USA - English Share this article Share this article TEL AVIV, Israel and BETHESDA, Md., May 25, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the company's patent titled: "System and Method for High Throughput Screening of Cancer Cells" has been granted by the European Patent Office. Outside the European territory, corresponding patents u...

Worldwide Liquid Handling System Industry to 2026 - Increasing Research Activities in Genomics and Proteomics Presents Opportunities - Vimarsana News

Worldwide Liquid Handling System Industry to 2026 - Increasing Research Activities in Genomics and Proteomics Presents Opportunities

Share this article Share this article ResearchAndMarkets.com's offering. The Global Liquid Handling System Market is estimated to be USD 3.53 Bn in 2021 and is expected to reach USD 4.98 Bn by 2026, growing at a CAGR of 7.1%. Market Dynamics Major factors that drive the market growth are increasing expenditure in research & development activities, growing technological advancements, the need for new drug development, and the growing demand for high-output screening. All these help in driving the market growth of the Global Liquid Handling System Market. In addition to this, rapid adoption of...

Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies - Vimarsana News

Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies

Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies Measuring the presence and performance of neutralizing antibodies is crucial in the fight against the coronavirus disease 2019 (COVID-19) pandemic. This allows us to glimpse how effective vaccines and antibody therapies are in conferring protective immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Researchers in Germany and the U.S. described 11 unique nanobodies (Nbs) specific for the SARS-CoV-2 spike receptor-binding domain (RBD), of which 8 Nbs potentially inhibit ...

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting - Vimarsana News

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting News provided by Share this article Share this article ROCKVILLE, Md., April 27, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapy's 24 th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. Presentations and posters will be available at https://www.asgct.org/. Oral presentations include: Abstract Title: Effects of Sexual Dimorphism and Gen...